Person looking into a microscope

Department of Brain Health News

The UNLV Department of Brain Health will advance research, education, and practice to benefit brain health and the care and treatment of people with brain disorders across the life span. Our faculty specialize in several areas that range from basic and clinical research in neurodegenerative disease, neuropsychology, and occupational therapy.

Current Brain Health News

People preparing to cut ribbon on new Fertitta Complex
Campus News | November 1, 2019

A collection of local, national, and international news stories highlighting the people and programs of UNLV.

A man in a labcoat is reflected in nearby glass.
Campus News | September 26, 2019

Lou Ruvo Center for Brain Health neurologist Dr. Jeffrey Cummings joins UNLV to help launch new program that will be crucial for an aging state population.

blood pressure equipment against white background
Campus News | June 27, 2019

Formerly called School of Allied Health Sciences, the renamed unit has also launched new department of brain health.

A 3D illustration of the human brain.
Research | May 21, 2019

New research unveils the anterior cingulate cortex’s role in memory retrieval and potential implications for dementia treatment.

Charles Bernick
People | October 11, 2018

Dr. Charles Bernick, School of Community Health Alumnus of the Year, has gotten Nevada into the thick of the fight against Alzheimer's.

Jefferson Kinney working in the lab.
Research | December 12, 2017

Neuroscientist Jefferson Kinney's work with Ruvo Center for Brain Health is improving patient care while expanding opportunities for UNLV student learning.

Brain Health In The News

MarketWatch
November 4, 2019

China has approved its first homegrown Alzheimer’s treatment — a novel drug based on algae, and the first breakthrough since 2003 in a field that has frustrated scientists and drug companies for decades.

Yahoo!
November 4, 2019

Shanghai Green Valley Pharmaceuticals (Green Valley) today announced that China's National Medical Products Administration (NMPA) has approved Oligomannate (GV-971) as new drug for the treatment of "mild to moderate Alzheimer's disease (AD) and improving cognitive function."

PR Newswire
November 4, 2019

Shanghai Green Valley Pharmaceuticals (Green Valley) announced today that China's National Medical Products Administration ( ANPM ) has approved oligo manato (GV-971) as a new drug for treatment of "Alzheimer's disease (AD) from benign to moderate and to improve cognitive function".

PR Newswire
November 2, 2019

Shanghai Green Valley Pharmaceuticals (Green Valley) today announced that China's National Medical Products Administration (NMPA) has approved Oligomannate (GV-971) as new drug for the treatment of "mild to moderate Alzheimer's disease (AD) and improving cognitive function."

KVVU-TV: Fox 5
October 19, 2019

Promising research is coming out of a new department at the University of Nevada, Las Vegas focused on brain health.

DailyHeralds
September 17, 2019

Dr. Jeffrey Cummings, a world-renowned Alzheimer's researcher and leader in clinical trials, has been named the recipient of the 2019 Melvin R. Goodes Prize for Excellence in Alzheimer's Drug Discovery. The prize, awarded by the Alzheimer's Drug Discovery Foundation (ADDF), recognizes leading researchers developing treatments for Alzheimer's disease and related dementias.

Brain Health Experts

An expert in behavioral neuroscience with concentrations in Alzheimer's disease and schizophrenia.
A renowned expert on Alzheimer's Disease and other neurodegenerative disorders. 

Recent Brain Health Accomplishments

July 22, 2019
Jefferson Kinney (Integrated Health Sciences) and James Hyman (Psychology) received a $601,576 grant from the National Institute on Aging of the National Institutes of Health for the research project "Aging and Hyperglycemia Alter Molecular Mechanisms and Hippocampal Oscillations Consistent with Alzheimer's Disease."